Edgewise Therapeutics, Inc. SEC filings EWTX
Edgewise Therapeutics, Inc. has 421 filings in SEC EDGAR's recent list, going back to Sep 26, 2019. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 7, 2026 | — |
| 424B5 | Prospectus supplement | Apr 2, 2025 | — |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| S-3ASR | Automatic shelf registration | May 10, 2024 | — |
| S-8 | Employee stock plan registration | May 9, 2024 | — |
| 424B5 | Prospectus supplement | Jan 19, 2024 | — |
| S-3MEF | Filing | Jan 19, 2024 | — |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| 424B5 | Prospectus supplement | Jun 16, 2023 | — |
| S-8 | Employee stock plan registration | May 11, 2023 | — |
| 424B5 | Prospectus supplement | Sep 14, 2022 | — |
| 424B5 | Prospectus supplement | Sep 13, 2022 | — |
| 424B5 | Prospectus supplement | May 5, 2022 | — |
| S-3 | Shelf registration | Apr 1, 2022 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| S-8 | Employee stock plan registration | Mar 26, 2021 | — |
| 424B4 | Prospectus | Mar 26, 2021 | — |
| S-1MEF | Filing | Mar 25, 2021 | — |
| S-1/A | Amended registration statement | Mar 24, 2021 | — |
| S-1/A | Amended registration statement | Mar 22, 2021 | — |
| S-1 | Registration statement | Mar 5, 2021 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boulder, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1710072
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.